Furthermore, because signals from the tumour microenvironment can influence MAPK signalling the dynamic regulation of MITF downstream of BRAF might explain at least in part the significant heterogeneity in MITF expression that is observed in human tumours. This evidence concerns the gene BRAF and neoplasm.